Shari O'Quinn

Shari O'Quinn is a seasoned leader in the Global MedTech industry, currently serving as the Chief Clinical, Regulatory, and Quality Officer at ONWARD Medical. With previous roles including Vice President of Clinical and Regulatory at TriVascular, Inc. and CR Bard, Shari has a proven track record in building clinical and regulatory infrastructures that support successful market entry for medical devices. Shari's expertise encompasses the development of go-to-market strategies and navigating complex regulatory landscapes, contributing to significant acquisitions, including her work at Aptus Endosystems, acquired by Medtronic. Shari's academic foundation was established at the University of Virginia, where they began their clinical research career.